Schneider PA, Varcoe RL, Secemsky E, Schermerhorn M, et al. Update on paclitaxel for femoral-popliteal occlusive disease in the 15 months following a summary level meta-analysis demonstrated increased risk of late mortality and dose response to paclitaxel. J Vasc Surg 2021;73:311-322.
PMID: 32890719